After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...